Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of AXSM will rise by +6.89% over the next 2 Weeks and hit $197.22 by Tuesday, February 3, 2026. In that time frame, AXSM's share price is expected to range between $190.79 and $204.28.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 3, 2026 | 190.79 | 197.22 | 204.28 |
| Feb 2, 2026 | 192.26 | 198.81 | 205.29 |
| Jan 30, 2026 | 191.72 | 198.43 | 205.07 |
| Jan 29, 2026 | 188.56 | 194.84 | 201.34 |
| Jan 28, 2026 | 191.47 | 198.07 | 204.58 |
| Jan 27, 2026 | 184.21 | 190.85 | 197.58 |
| Jan 26, 2026 | 186.07 | 192.45 | 199.24 |
| Jan 23, 2026 | 185.48 | 192.06 | 198.45 |
| Jan 22, 2026 | 181.93 | 188.47 | 195.08 |
| Jan 21, 2026 | 185.28 | 191.71 | 198.51 |
AXSM shares rose +1.90% in Wednesday, January 21, 2026's trading session, rising from a previous close of $184.50 to move at $188.01. The stock demonstrated notable intraday movement (see AXSM's key stats for a full breakdown), fluctuating between $183.69 and $188.29, a +2.50% trading range. While recent weeks have seen some volatility, AXSM has managed to secure a +9.38% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.2M shares changing hands, 594.77K more than the previous session. This amounted to $225.46M in total market activity.
Will AXSM Continue Its Upward Trend?
According to analyst ratings and projections for AXSM, Axsome Therapeutics, Inc. shares are anticipated to increase by +7.97%, potentially reaching $204.28 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for AXSM. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the AXSM stock forecast, now is a good time to buy AXSM stock because its current trading price is -4.67% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on AXSM covering social and institutional perspectives.
AXSM Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into AXSM's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 69.35% to 73.93%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 65.45%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 61.81%, points to growing bullish momentum over the long term. Insights into AXSM's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Axsome Therapeutics Short-Term Forecasts
AXSM Forecast For Next 5 Days
Our algorithm anticipates Axsome Therapeutics (AXSM) stock could hit $175.04 by Jan 28, 2026. This represents a -6.89% rise from today's price, following a +4.34% change over the past five days.
AXSM Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Axsome Therapeutics, Inc. (AXSM) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $185.63, which would mean a -1.26% decrease from the current price of $188.01. Projections for this period range from a high of $199.84 to a low of $168.15.
AXSM Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Axsome Therapeutics's price over the next three months point to a drop. AXSM stock is expected to peak at $184.28 on Apr 17, 2026 after potentially dipping to $164.87 on Feb 03, 2026. On average, AXSM is likely to trade around $175.35 in the coming 90 days.
Axsome Therapeutics Stock Forecast 2025
Based on our predictive models, Axsome Therapeutics (AXSM) is expected to trade between $164.87 and $207.73 throughout 2026. This would result in an average price of $184.35, potentially offering investors a -1.94% return from current levels.
Axsome Therapeutics, Inc. Monthly Forecast 2026–2027
January 2026
According to our latest forecast models, Axsome Therapeutics, Inc. (AXSM) is positioned to show a strong performance in January 2026. The price is predicted to move between $165.42 and $177.81, settling at an average of $171.21. This could translate to a -8.93% loss.
February 2026
Based on current market signals, Axsome Therapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $164.87 to $183.38, with a likely average price of $173.86. Investors could expect a potential return of -7.52%.
March 2026
Our predictive algorithms indicate Axsome Therapeutics, Inc. stock may see a shift in March 2026. The expected range spans $170.21–$183.08, with an average target of $176.93. This represents a cautious outlook and a possible loss of -5.89%.
April 2026
Analyzing established trends, Axsome Therapeutics, Inc. looks set to move in April 2026. Projections place the stock between $170.94 and $186.25, averaging around $178.01. This suggests a -5.32% loss from current levels.
May 2026
Market indicators suggest Axsome Therapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $175.09 to $189.91, with a midpoint forecast of $182.97. The stock might deliver a -2.68% loss.
June 2026
Forecasting for June 2026, models estimate that Axsome Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $174.36 and $194.36, averaging $183.66. This signals a cautious trajectory with potential returns around -2.31%.
July 2026
According to our latest forecast models, Axsome Therapeutics, Inc. (AXSM) is positioned to show a strong performance in July 2026. The price is predicted to move between $174.86 and $192.48, settling at an average of $183.74. This could translate to a -2.27% loss.
August 2026
Based on current market signals, Axsome Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $180.03 to $192.30, with a likely average price of $186.33. Investors could expect a potential return of -0.89%.
September 2026
Our predictive algorithms indicate Axsome Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $179.68–$195.85, with an average target of $187.84. This represents a cautious outlook and a possible loss of -0.09%.
October 2026
Analyzing established trends, Axsome Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $182.06 and $199.00, averaging around $192.19. This suggests a +2.23% gain from current levels.
November 2026
Market indicators suggest Axsome Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $183.34 to $207.73, with a midpoint forecast of $193.20. The stock might deliver a +2.76% gain.
December 2026
Forecasting for December 2026, models estimate that Axsome Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $185.01 and $201.87, averaging $193.61. This signals a positive trajectory with potential returns around +2.98%.
January 2027
According to our latest forecast models, Axsome Therapeutics, Inc. (AXSM) is positioned to show a strong performance in January 2027. The price is predicted to move between $189.38 and $201.33, settling at an average of $195.53. This could translate to a +4.00% gain.
AXSM's history of dividends and stock splits also plays a role in long-term investor confidence.

